vs
Childrens Place, Inc.（PLCE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Childrens Place, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.6倍（$339.5M vs $207.3M），Childrens Place, Inc.净利率更高（-1.3% vs -62.0%，领先60.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -13.0%），Childrens Place, Inc.自由现金流更多（$-3.4M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -13.6%）
Children’s Place是专业儿童服饰零售商，产品主要以旗下自有品牌发售，涵盖Gymboree、Sugar & Jade、PJ Place、Crazy 8等。目前该品牌在美国、加拿大、波多黎各共开设约525家门店，同时通过两个线上渠道以及15个国家的5家加盟合作伙伴开展销售，产品涵盖上衣、裙装、鞋履、裤装、睡衣、背包等全品类儿童服饰配件。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PLCE vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $339.5M | $207.3M |
| 净利润 | $-4.3M | $-128.6M |
| 毛利率 | 33.1% | — |
| 营业利润率 | 1.1% | -54.7% |
| 净利率 | -1.3% | -62.0% |
| 营收同比 | -13.0% | 25.9% |
| 净利润同比 | -121.5% | 3.5% |
| 每股收益（稀释后） | $-0.19 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $339.5M | $207.3M | ||
| Q3 25 | $298.0M | $159.9M | ||
| Q2 25 | $242.1M | $166.5M | ||
| Q1 25 | $408.6M | $139.3M | ||
| Q4 24 | $390.2M | $164.6M | ||
| Q3 24 | $319.7M | $139.5M | ||
| Q2 24 | $267.9M | $147.0M | ||
| Q1 24 | $455.0M | $108.8M |
| Q4 25 | $-4.3M | $-128.6M | ||
| Q3 25 | $-5.4M | $-180.4M | ||
| Q2 25 | $-34.0M | $-115.0M | ||
| Q1 25 | $-8.0M | $-151.1M | ||
| Q4 24 | $20.1M | $-133.2M | ||
| Q3 24 | $-32.1M | $-133.5M | ||
| Q2 24 | $-37.8M | $-131.6M | ||
| Q1 24 | $-128.8M | $-170.7M |
| Q4 25 | 33.1% | — | ||
| Q3 25 | 34.0% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 28.5% | — | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.0% | — | ||
| Q2 24 | 34.6% | — | ||
| Q1 24 | 21.8% | — |
| Q4 25 | 1.1% | -54.7% | ||
| Q3 25 | 1.4% | -106.9% | ||
| Q2 25 | -10.0% | -64.8% | ||
| Q1 25 | 1.7% | -102.6% | ||
| Q4 24 | 7.5% | -74.3% | ||
| Q3 24 | -6.8% | -94.6% | ||
| Q2 24 | -10.4% | -79.1% | ||
| Q1 24 | -13.6% | -151.9% |
| Q4 25 | -1.3% | -62.0% | ||
| Q3 25 | -1.8% | -112.8% | ||
| Q2 25 | -14.1% | -69.0% | ||
| Q1 25 | -2.0% | -108.5% | ||
| Q4 24 | 5.1% | -80.9% | ||
| Q3 24 | -10.0% | -95.7% | ||
| Q2 24 | -14.1% | -89.5% | ||
| Q1 24 | -28.3% | -156.8% |
| Q4 25 | $-0.19 | $-1.28 | ||
| Q3 25 | $-0.24 | $-1.81 | ||
| Q2 25 | $-1.57 | $-1.17 | ||
| Q1 25 | $-0.60 | $-1.57 | ||
| Q4 24 | $1.57 | $-1.34 | ||
| Q3 24 | $-2.51 | $-1.40 | ||
| Q2 24 | $-2.98 | $-1.52 | ||
| Q1 24 | $-10.24 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.3M | $421.0M |
| 总债务越低越好 | $107.4M | — |
| 股东权益账面价值 | $-8.6M | $-80.0M |
| 总资产 | $762.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $7.3M | $421.0M | ||
| Q3 25 | $7.8M | $202.5M | ||
| Q2 25 | $5.7M | $176.3M | ||
| Q1 25 | $5.3M | $127.1M | ||
| Q4 24 | $5.7M | $174.0M | ||
| Q3 24 | $9.6M | $150.6M | ||
| Q2 24 | $13.0M | $480.7M | ||
| Q1 24 | $13.6M | $112.3M |
| Q4 25 | $107.4M | — | ||
| Q3 25 | $107.2M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $166.0M | — | ||
| Q4 24 | $165.7M | — | ||
| Q3 24 | $165.4M | — | ||
| Q2 24 | $166.6M | — | ||
| Q1 24 | $49.8M | — |
| Q4 25 | $-8.6M | $-80.0M | ||
| Q3 25 | $-4.9M | $9.2M | ||
| Q2 25 | $1.4M | $151.3M | ||
| Q1 25 | $-59.4M | $144.2M | ||
| Q4 24 | $-49.6M | $255.0M | ||
| Q3 24 | $-68.9M | $346.8M | ||
| Q2 24 | $-34.9M | $432.4M | ||
| Q1 24 | $-9.0M | $140.3M |
| Q4 25 | $762.5M | $1.5B | ||
| Q3 25 | $805.1M | $1.2B | ||
| Q2 25 | $779.6M | $1.3B | ||
| Q1 25 | $747.6M | $1.3B | ||
| Q4 24 | $888.8M | $1.5B | ||
| Q3 24 | $921.4M | $1.5B | ||
| Q2 24 | $848.3M | $1.6B | ||
| Q1 24 | $800.3M | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 75.63× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-3.4M | $-100.8M |
| 自由现金流率自由现金流/营收 | -1.0% | -48.6% |
| 资本支出强度资本支出/营收 | 2.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $39.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $6.2M | $-99.8M | ||
| Q3 25 | $-30.5M | $-91.4M | ||
| Q2 25 | $-43.0M | $-108.3M | ||
| Q1 25 | $121.3M | $-166.5M | ||
| Q4 24 | $-44.2M | $-79.3M | ||
| Q3 24 | $-83.9M | $-67.0M | ||
| Q2 24 | $-110.8M | $-77.0M | ||
| Q1 24 | $135.4M | $-190.7M |
| Q4 25 | $-3.4M | $-100.8M | ||
| Q3 25 | $-31.9M | $-92.7M | ||
| Q2 25 | $-46.4M | $-110.7M | ||
| Q1 25 | $121.2M | $-167.8M | ||
| Q4 24 | $-47.7M | $-79.5M | ||
| Q3 24 | $-91.7M | $-68.6M | ||
| Q2 24 | $-115.5M | $-79.0M | ||
| Q1 24 | $132.2M | $-193.9M |
| Q4 25 | -1.0% | -48.6% | ||
| Q3 25 | -10.7% | -58.0% | ||
| Q2 25 | -19.2% | -66.5% | ||
| Q1 25 | 29.7% | -120.5% | ||
| Q4 24 | -12.2% | -48.3% | ||
| Q3 24 | -28.7% | -49.2% | ||
| Q2 24 | -43.1% | -53.7% | ||
| Q1 24 | 29.1% | -178.2% |
| Q4 25 | 2.8% | 0.5% | ||
| Q3 25 | 0.5% | 0.8% | ||
| Q2 25 | 1.4% | 1.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.9% | 0.1% | ||
| Q3 24 | 2.4% | 1.2% | ||
| Q2 24 | 1.8% | 1.4% | ||
| Q1 24 | 0.7% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLCE
| The Childrens Place US | $307.4M | 91% |
| The Childrens Place International | $32.1M | 9% |
| Gift Cards | $1.7M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
